Siegfried AG · ISIN: CH0014284498 · EQS - Company News

Changes in Siegfried's senior management team

Siegfried AG / Key word(s): Personnel Changes in Siegfried's senior management team 06.12.2024 / 06:30 CET/CEST Media Release Zofingen, December 6, 2024 Stefan Randl will join as Chief Scientific Officer and member of the Executive Committee as of January 1, 2025. He will succeed Jürgen Roos who has decided to leave the company to take a well-deserved sabbatical. Stefan joins from Evonik, where he has held various leadership positions in several regions over the past 16 yea...

SIX:SFZN Price indication powered by TradingView

About the publication

Corporate Insights - Short Sales, Director's Dealings, Sentiment Indicators - THE info hub for the informed investor

Smart tools for smart investors can be found in our Tools section

Corporate News Siegfried AG

In this overview you can view company news in the chronological order of publication. The source information comes from EQS News, the leading European news distributor. The most recent news item is listed first.
Back to Corporate News Overview
This might be interesting for you as well
Analyst Ratings (0)
Directors Dealings (0)
Short Selling (DE) (0)
Short Selling (UK) (0)
06 December 2024 06:30AM
Changes in Siegfried's senior management team
CH0014284498
Siegfried AG / Key word(s): Personnel Changes in Siegfried's senior management team 06.12.2024 / 06:30 CET/CEST Media Release Zofingen, December 6, 2024 Stefan Randl will join as Chief Scientific Officer and member of the Executive Committee as of January 1, 2025. He will succeed Jürgen Roos who has decided to leave the compan...
Siegfried AG
About the publication
19 November 2024 07:03AM
Siegfried opens new global R&D Center for Drug Substances in Evionnaz
CH0014284498
Siegfried AG / Key word(s): Expansion Siegfried opens new global R&D Center for Drug Substances in Evionnaz 19.11.2024 / 07:03 CET/CEST Media Release Zofingen, November 19, 2024 Siegfried (SIX: SFZN), a leading global Contract Development and Manufacturing Organization (CDMO) for the pharmaceutical industry headquartered i...
Siegfried AG
About the publication
12 November 2024 06:30AM
DINAMIQS opens new lab in Zurich
CH0014284498
Siegfried AG / Key word(s): Expansion DINAMIQS opens new lab in Zurich 12.11.2024 / 06:30 CET/CEST Media Release Zofingen, November 12, 2024 Siegfried (SIX: SFZN), a leading global Contract Development and Manufacturing Organization (CDMO) for the pharmaceutical industry headquartered in Zofingen (Switzerland), reached another...
Siegfried AG
About the publication
24 October 2024 06:30AM
Strategy EVOLVE+ paves the way for continued profitable growth
CH0014284498
Siegfried AG / Key word(s): Strategic Company Decision Strategy EVOLVE+ paves the way for continued profitable growth 24.10.2024 / 06:30 CET/CEST Media Release Zofingen, October 24, 2024 Siegfried (SIX: SFZN), a leading global Contract Development and Manufacturing Organization (CDMO) for the pharmaceutical industry headquarte...
Siegfried AG
About the publication
04 September 2024 06:30AM
EGS Beteiligungen AG exercises right to convert bond and increases its shareholding in Siegfried to 7.2% registered shares
CH0014284498
EGS Beteiligungen AG exercised its right to convert also the second of the two convertible bonds issued in December 2020 with a coupon of 1.15% and a nominal value of CHF 40m into shares of Siegfried Holding AG. EGS Beteiligungen AG will receive 48'054 shares and as a result will increase its stake in Siegfried from 6.2% to about 7.2% registered sh...
Siegfried AG
About the publication
30 August 2024 06:30AM
Siegfried opens new quality control lab in Minden
CH0014284498
Siegfried AG / Key word(s): Miscellaneous Siegfried opens new quality control lab in Minden 30.08.2024 / 06:30 CET/CEST Siegfried inaugurated its new state-of-the-art quality control lab in Minden. The new facility further improves the operational efficiency and readies the site for the completion of the new large-scale produc...
Siegfried AG
About the publication
22 August 2024 06:30AM
Siegfried continues to grow and increases profitability
CH0014284498
In the first half of 2024, Siegfried (SIX: SFZN) continued its journey of profitable growth. Significant progress has been made in the implementation of the corporate strategy EVOLVE which is geared towards long-term profitable growth in core areas and beyond. Net sales amounted to CHF 619.9 million, an increase of 3.5% in local currencies (2.1% i...
Siegfried AG
About the publication
10 July 2024 06:30AM
Marcel Imwinkelried appointed as new CEO
CH0014284498
The Board of Directors of Siegfried Holding AG has appointed Marcel Imwinkelried as the new CEO with effect as of September 1, 2024. He will succeed Reto Suter, who has been leading the Siegfried Group as CEO ad interim since May 1, 2024, and will now focus again on his role as CFO. Marcel Imwinkelried (1967) joined the Siegfried Group in January 2...
Siegfried AG
About the publication
02 July 2024 06:30AM
Siegfried successfully completes acquisition of an early-phase CDMO in Wisconsin (US)
CH0014284498
Siegfried AG / Key word(s): Acquisition Siegfried successfully completes acquisition of an early-phase CDMO in Wisconsin (US) 02.07.2024 / 06:30 CET/CEST Siegfried (SIX: SFZN) has completed the acquisition of an early-phase CDMO site in Grafton, Wisconsin (US) from Curia Global, strengthening Siegfried's customer offering for ...
Siegfried AG
About the publication
14 June 2024 06:30AM
EGS Beteiligungen AG exercises right to convert bond and increases its shareholding in Siegfried to 6.2% registered shares
CH0014284498
  EGS Beteiligungen AG exercised its right to convert one of the convertible bonds issued in December 2020 with a coupon of 0.650% and a nominal value of CHF 40m into shares. EGS Beteiligungen will receive 51'899 shares of Siegfried Holding AG and as a result will increase its stake in Siegfried from 5.0% to about 6.2% registered shares (about 7.2...
Siegfried AG
About the publication
12 June 2024 06:30AM
Siegfried to acquire an early-phase CDMO in Wisconsin (US) to strengthen its Drug Substances service offering
CH0014284498
Siegfried to acquire a CDMO specialized in early-phase development and manufacturing services in Grafton, Wisconsin (US) The new site is set to strengthen Siegfried's customer offering for Drug Substances in terms of capabilities and geography Siegfried will further develop the site into its North American Siegfried Acceleration Hub for early-pha...
Siegfried AG
About the publication
More Siegfried AG related information
Type Total Last Made by Go to
Corporate Research 0 - - Corporate Research
Directors Dealings 0 - - DD
Short Seller (DE) 0 - - SSR (DE)
Short Seller (UK) 0 - - SSR (UK)
Disclaimer:

The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster. 
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.

If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.

v.07062023 EN